Aiming to encourage and inspire more physicians to develop careers that blend scientific research with patient care, the Burroughs Wellcome Fund has announced that Washington University School of Medicine in St. Louis will receive a prestigious, $2.5 million Physician-Scientist Institutional Award.

Scientists at the School of Medicine have pinpointed the precise cause of Krabbe disease, a neurodegenerative condition that usually causes death by age 3.

A single high dose of radiation aimed at the heart significantly reduces episodes of a potentially deadly rapid heart rhythm, according to results of a phase one/two study at the School of Medicine.

Brown School researchers at Washington University in St. Louis have begun work on a five-year, $3.9 million study that tests an innovative approach to help low-income smokers quit: helping people establish rules banning smoking inside their homes.

The School of Medicine has received a $5 million grant from the Edward P. Evans Foundation to establish and endow a new center focused on advancing research and improving treatments for a rare set of blood disorders called myelodysplastic syndromes, or MDS, that leaves the body unable to make enough healthy blood cells.

As part of a federal initiative to end the HIV epidemic, Washington University in St. Louis will establish a center to provide guidance and support to local organizations working to reduce HIV infection rates in their communities. Among other things, the center will help organizations provide PrEP, a medicine that prevents HIV infection.

Michael J. Holtzman, MD, director of the School of Medicine’s Division of Pulmonary & Critical Care Medicine, has received awards totaling $7.5 million to support innovative research aimed at defining and controlling chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease.

Nearly all babies born prematurely receive antibiotics. A new study from the School of Medicine suggests that such early antibiotic treatment could have long-lasting and potentially harmful effects on the gut microbiome.

The Community Academic Partnership on Addiction Clinic, a partnership between the Brown School and Preferred Family Healthcare, was able to increase treatment completion rates by 11% over a six-month time period.

A test for signs of Zika infection has been granted market authorization by the Food and Drug Administration. The test is based in part on an antibody developed by researchers at the School of Medicine.